Education of Visually Impaired Children: A Survey of Priorities in New York State

1982 ◽  
Vol 76 (2) ◽  
pp. 53-57 ◽  
Author(s):  
Rosanne K. Silberman

This article describes the results of a Needs Assessment Questionnaire mailed to professionals, paraprofessionals, and parents in New York State who were involved in the education of visually impaired and blind children. The information obtained was used to plan a conference on Educational Issues of Students with Visual Impairments that would be of interest not only to most people who attended but to various subgroups divided according to geographic location, type of position, type of program, educational background, teacher certification, and years of experience in the field. Respondents were presented with a list of 33 topics and asked to grade each one as follows: (1) high priority, (2) important, (3) low priority, or (4) not interested. The ten topics selected as the highest priorities by all respondents (N = 207) and by different subgroups are discussed.

1979 ◽  
Vol 73 (6) ◽  
pp. 228-232
Author(s):  
Norman J. Weiss

Describes a three-part driving program for low vision persons. Potential trainees are first interviewed to detect problems that may interfere with success. Suitable candidates are then trained to quickly detect and recognize objects through a bioptic lens system. In the third phase, a mobility instructor gives training in various aspects of the automobile and driving, and the trainee is quizzed on road signs and markings while riding as a passenger. Students successfully completing all three phases may then go on to obtain a Learner's Permit and take driving lessons in the usual manner.


2017 ◽  
Vol 24 (2) ◽  
pp. 133-138 ◽  
Author(s):  
Jonathan S. Abelson ◽  
Joshua D. Spiegel ◽  
Heather L. Yeo ◽  
Jialin Mao ◽  
Tianyi Sun ◽  
...  

Background: Fecal incontinence (FI) represents a large source of morbidity and is a challenging clinical problem to manage. InterStim was approved to treat FI in 2011. Little is known about its adoption. We sought to characterize patterns of use of Interstim since Food and Drug Administration approval for FI. Methods: The New York State SPARCS database was used to evaluate InterStim use for FI from 2011 to 2014. The primary endpoint was the number of successful implantations of InterStim. Secondary endpoints included device removal, median time to removal of device, 90-day infection rates, and percentage of procedures performed by surgeon specialty and geographic location. Results: A total of 369 patients with FI underwent “Stage 1” of InterStim from 2011 to 2014. A total of 302 patients underwent “Stage 2,” yielding a trial period failure rate of 18.2%. The majority of patients who underwent successful implantation were female (87.7%) and White (78.8%). Twenty-nine patients underwent device removal after a median duration of 147 days. Estimated risk of removal at median follow-up of 2 years was 11.8%. Colorectal surgeons comprised 51.1% of all providers followed by gynecologic (24.4%) and urologic surgeons (17.8%). A total of 71.7% of providers performed <5 procedures, while 3 of the highest volume providers performed 50.7% of all procedures. Conclusions: InterStim for FI has been used by a wide variety of providers in New York State although only a few high-volume providers have performed the majority of procedures. White, female patients with Medicare are the most common recipients of InterStim. Further work must be done to develop strategies for improving access to this technology and to determine whether volume relates to outcomes.


Sign in / Sign up

Export Citation Format

Share Document